DESIGN AND SYNTHESIS OF NOVEL POLY ADP-RIBOSE POLYMERASE 1 (PARP1) INHIBITORS FOR THE TREATMENT OF SOLID TUMORS

被引：0
|
作者：
Priyancy, J. [1 ]
Bhumika, D. P. [1 ]
机构：
[1] Nirma Univ, Inst Pharm, Dept Pharmaceut Chem, Ahmadabad 382481, Gujarat, India
来源：
CONFERENCE ON DRUG DESIGN AND DISCOVERY TECHNOLOGIES | 2020年 / 355卷
关键词：
MOLECULAR DOCKING; DNA-REPAIR;
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：31 / 35
页数：5
相关论文
共 50 条
  • [1] In-silico designing and synthesis of novel and selective hits as Poly ADP-Ribose Polymerase 1 (PARP1) inhibitors for treatment of solid tumours
    Jain, Priyancy
    Patel, Bhumika
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [2] Design, synthesis, and biological evaluation of novel chrysin derivatives as poly(ADP-ribose) polymerase 1(PARP1) inhibitors for the treatment of breast cancer
    YANG Yao
    TONG Jing
    XIE Xianshun
    CAO Hong
    FU Yong
    LUO Yong
    LIU Shan
    CHEN Wen
    YANG Ning
    Chinese Journal of Natural Medicines, 2024, 22 (05) : 455 - 465
  • [3] Design, synthesis and SAR evaluation of imidazobenzodiazepines as potent poly(ADP-ribose)polymerase-1 (PARP1) inhibitors.
    Ferraris, D
    Pargas, R
    Dain, D
    Ginski, M
    Lautar, S
    Lee-Wisdom, K
    Liang, S
    Lin, Q
    Lu, XCM
    Morgan, L
    Thomas, B
    Tran, S
    Williams, L
    Xu, W
    Zhang, J
    Zao, YN
    Kalish, VJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U53 - U54
  • [4] Poly(ADP-ribose) polymerase1 (PARP1) and PARP inhibitors: New frontiers in cervical cancer
    Rajawat, Jyotika
    Banerjee, Monisha
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 738
  • [5] Relevance of Poly(ADP-ribose) Polymerase 1 (PARP1) in Experimental Colitis
    Larmonier, Claire B.
    Shehab, Kareem W.
    McFadden, Rita-Marie T.
    Hill, Faihza M.
    Alizadeh, Darya
    Thurston, Robert D.
    Kiela, Pawel R.
    Ghishan, Fayez K.
    GASTROENTEROLOGY, 2014, 146 (05) : S644 - S644
  • [6] Design, synthesis, and biological evaluation of novel chrysin derivat-ives as poly(ADP-ribose) polymerase 1 (PARP1) inhibitors for the treatment of breast cancer
    Yang, Yao
    Tong, Jing
    Xie, Xianshun
    Cao, Hong
    Fu, Yong
    Luo, Yong
    Liu, Shan
    Chen, Wen
    Yang, Ning
    CHINESE JOURNAL OF NATURAL MEDICINES, 2024, 22 (05) : 455 - 465
  • [7] Design and synthesis of novel, potent poly(ADP-ribose) polymerase (PARP) inhibitors.
    Xu, WZ
    Liu, Q
    Chen, JA
    Ko, YS
    Li, JH
    Lu, M
    Tran, S
    Zhang, J
    Kalish, V
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U53 - U53
  • [8] Design, synthesis and SAR evaluation of novel inhibitors of poly(ADP-ribose)polymerase (PARP).
    Musick, KY
    Weintraub, PM
    Eastwood, P
    Mehdi, S
    Koehl, J
    Kominos, D
    Schreuder, H
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U22 - U22
  • [9] Modulatory Potential of Poly (ADP-Ribose) Polymerase 1 (PARP1) in BRCA-Mutated Tumors
    Munyembaraga, Valens
    Cyuzuzo, Delphine
    Dao, Tran Nhat Phong
    Oyinloye, Babatunji Emmanuel
    Onikanni, Sunday Amos
    Chang, Hen-Hong
    EUROPEAN JOURNAL OF CANCER CARE, 2024, 2024
  • [10] MEDI 303-Design and synthesis of novel inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
    Patel, Maulik R.
    Pino, Maria
    Billack, Blase
    Talele, Tanaji T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
12345